Peptide Library

A long-acting GLP-1 receptor agonist and the most rigorously studied weight-management peptide in modern medicine, with cardiovascular outcome data from tens of thousands of patients.

aka Ozempic, Wegovy, Rybelsus

A dual GIP/GLP-1 receptor agonist that produced the largest weight reductions ever recorded for a non-surgical intervention in randomized trials.

aka Mounjaro, Zepbound

A synthetic pentadecapeptide derived from human gastric juice protein BPC, with an extensive rodent literature on tendon, ligament, gut, and nerve healing — and almost no controlled human data.

aka Body Protection Compound 157, Pentadecapeptide BPC 157

A synthetic fragment of the actin-sequestering protein thymosin beta-4, studied in cardiac repair and corneal/dermal wound healing, and heavily used off-label in veterinary and grey-market human settings.

aka TB4 fragment, Tβ4 17-23

The most common growth-hormone secretagogue pairing: a GHRH analogue combined with a selective ghrelin-receptor agonist, intended to raise endogenous GH pulses rather than inject exogenous GH.

aka Mod GRF 1-29 stack, GHRH + ghrelin mimetic

The only FDA-approved GHRH analogue, indicated for HIV-associated lipodystrophy, and one of the few peptides with randomized evidence for visceral-fat reduction and liver-fat improvement.

aka Egrifta

A heptapeptide ACTH fragment approved in Russia for stroke and cognitive indications, with essentially no Western regulatory recognition and a modest but real clinical literature.

aka ACTH(4-10) analogue, Met-Glu-His-Phe-Pro-Gly-Pro

A synthetic tetrapeptide from the Russian gerontology literature, claimed to modulate telomerase and pineal melatonin rhythms, with long-term mortality data that has never been independently replicated.

aka Epithalon, AEDG peptide

An immunomodulating thymic peptide approved in more than 30 countries for hepatitis B/C and used as an adjuvant in sepsis and oncology settings, though not FDA-approved.

aka Tα1, Zadaxin

A copper-binding tripeptide present in human plasma and the best-supported cosmetic peptide, with in-vitro and small clinical evidence for collagen synthesis and skin remodeling.

aka Copper tripeptide-1, Gly-His-Lys copper

An investigational triple agonist of GIP, GLP-1, and glucagon receptors that produced roughly 24% weight loss at 48 weeks in Phase II — the highest figure yet reported for a pharmacologic agent.

aka LY3437943, triple-G agonist

A melanocortin receptor agonist approved for hypoactive sexual desire disorder in premenopausal women — a rare case of a 'lifestyle' peptide clearing full FDA review.

aka Vyleesi, bremelanotide